Iovance Biotherapeutics Inc
LSE:0JDK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Iovance Biotherapeutics Inc
LSE:0JDK
|
US |
|
B
|
Britania PCL
SET:BRI
|
TH |
|
W
|
Waters Corp
DUS:WAZ
|
US |
|
S
|
Service Corporation International
F:SVC
|
US |
|
Lument Finance Trust Inc
F:70X
|
US |
|
B
|
BAE Systems PLC
F:BSP
|
UK |
|
S
|
Schlumberger NV
XHAM:SCL
|
US |
|
A
|
Assicurazioni Generali SpA
SWB:ASG
|
IT |
|
I
|
Iss A/S
LSE:0QRS
|
DK |
|
P
|
Precigen Inc
F:I5X
|
US |
|
Shopify Inc
NASDAQ:SHOP
|
CA |
|
M
|
Matador Resources Co
XBER:7MR
|
US |
|
Pilot Corp
TSE:7846
|
JP |
|
Publicis Groupe SA
F:PU41
|
FR |
|
J
|
Japan Tobacco Inc
DUS:JAT
|
JP |
|
R
|
Ramkhamhaeng Hospital PCL
SET:RAM
|
TH |
|
D
|
Dohome PCL
SET:DOHOME
|
TH |
|
H
|
Hapag Lloyd AG
OTC:HLAGF
|
DE |
|
Tapestry Inc
NYSE:TPR
|
US |
|
A
|
ADT Inc
F:541
|
US |
|
Merck & Co Inc
NYSE:MRK
|
US |
|
N
|
Nephros Inc
F:NPJP
|
US |
|
D
|
Daily Mail and General Trust P L C
F:DGW2
|
UK |
|
F
|
Flowserve Corp
XMUN:FWV
|
US |
Wall St Price Targets
0JDK Price Targets Summary
Iovance Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for 0JDK is 9.631 USD with a low forecast of 6.023 USD and a high forecast of 13.567 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0JDK's stock price target?
Price Target
9.631
USD
According to Wall Street analysts, the average 1-year price target for 0JDK is 9.631 USD with a low forecast of 6.023 USD and a high forecast of 13.567 USD.
What is the Revenue forecast for Iovance Biotherapeutics Inc?
Projected CAGR
29%
The compound annual growth rate for Revenue over the next 8 years is 29%.
What is the Gross Profit forecast for Iovance Biotherapeutics Inc?
Projected CAGR
43%
The compound annual growth rate for Gross Profit over the next 8 years is 43%.
